Pharmaceuticals company Fermenta Biotech announced Q3FY25 results Revenue: Rs 156.5 crore (up 58 % YoY, up 65 % QoQ). EBITDA: Rs 55.5 crore (up 101 % YoY, up 156 % QoQ). Profit after tax: Rs 37.9 crore (up 279 % YoY, up 241 % QoQ). EPS: Rs 12.71 (up 273 % YoY, up 222 % QoQ). Prashant Nagre, Managing Director, said: “The significant YoY and QoQ increase in revenue and EBITDA was on the back of volume and price growth in both Human and Animal Nutrition. Increased market demand in the Human Nutrition segment in key markets such as North America and Europe; approvals with key global accounts in animal nutrition also led to increased volumes in this segment.” Result PDF